Sterinova Uses Needle-Trap Secu with New Seal Function from Schreiner MediPharm
By introducing Needle-Trap Secu Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, is setting new standards in terms of efficiency and environmental protection. Sterinova, a Canadian subsidiary of the medical technology company B.
Successfully Protected: Robust RFID-Label
The Robust RFID-Label from Schreiner MediPharm has now been successful for five years and is therefore celebrating a somewhat special anniversary. Sebastian Münscher, Product Manager RFID/NFC Solutions, talks about the special features of this unique solution and new market findings.
Smart and Flexible: RFID Late Stage Customization
Continually changing market conditions and growing segmentation trends pose special challenges to the pharmaceutical industry. Flexibility and agility are necessary to ensure security of supply. In that context, Schreiner MediPharm is presenting an innovative solution: Late Stage Customization is now
Sustainable and Secure: Closure Seals Combine Environmental Protection and Functionality
Schreiner MediPharm is extending its portfolio of security solutions by new sustainable closure seals for pharmaceutical packaging. The tailored seals are perfectly adapted to the respective packaging and specific threat scenarios offering not only reliable functionality but also supporting the
Reduced Gas Ingress: The Barrier Inside the Label
Novel medicines based on large and complex molecules react very sensitively to oxygen and other gases. If the drugs come into contact with these, they begin to oxidize. That must be prevented because oxidation can have a negative impact on
Adherence Monitoring: Digital and Child-Resistant
With Schreiner MediPharm’s Smart Blister Wallets, medication adherence in clinical trials can be monitored digitally and in real time. Supported by its partner Keystone, a leading US designer and manufacturer of pharmaceutical paperboard packaging, Schreiner MediPharm is now extending its
Investigational Drug or Placebo – Blinding with Transparency
To ensure that clinical trial participants don’t know whether they are receiving the investigational drug or merely a placebo, the substances must be indistinguishable from each other. Schreiner MediPharm has developed a reliable blinding solution for vials used for clinical
Concentrated Expertise: Packaging Seminar
In the middle of September 2023, the two packaging specialists SGD Pharma and Schreiner MediPharm jointly conducted a two-day seminar to provide participants from the pharmaceutical industry with insights into glass and label manufactur¬ing and to inform them about current
mRNA Substances: Deep-freeze Label plus Light Protection
Novel therapies and vaccines based on mRNA substances as well as cell and gene therapies are becoming increasingly important , but these active pharmaceutical ingredients (APIs) are particularly sensitive. They are stored and transported on dry ice at temperatures of
Smart Adherence Monitoring: Digitally Documented
Due to aging populations, the number of patients who are prescribed several drugs at the same time is increasing. In addition, the need for personal visits to doctor’s offices is declining as patients increasingly receive digital care and home deliveries